SUBSTITUTED TRICYCLIC COMPOUNDS

Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, Formula (I) wherein, ring A, R1 to R5, X, Y, m, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferativ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PHUKAN, Samiron, SINDKHEDKAR, Milind, PALLE, Venkata, NAIR, Prathap, WAGH, Pradip, KAMBOJ, Rajender, DUBE, Dagadu, KHEDKAR, Nilesh, SETHI, Sachin, BALGUDE, Sudhakar, PATIL, Pradeep, TAMBE, Vikas, SHUKLA, Manojkumar, KAKADE, Ganesh
Format: Patent
Sprache:eng ; lit
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PHUKAN, Samiron
SINDKHEDKAR, Milind
PALLE, Venkata
NAIR, Prathap
WAGH, Pradip
KAMBOJ, Rajender
DUBE, Dagadu
KHEDKAR, Nilesh
SETHI, Sachin
BALGUDE, Sudhakar
PATIL, Pradeep
TAMBE, Vikas
SHUKLA, Manojkumar
KAKADE, Ganesh
description Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, Formula (I) wherein, ring A, R1 to R5, X, Y, m, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_LT4065575TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>LT4065575TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_LT4065575TT3</originalsourceid><addsrcrecordid>eNrjZJAPDnUKDvEMCQ1xdVEICfJ0jnT28XRWcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8T4hJgZmpqbmpiEhxkQoAQDLACIu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED TRICYCLIC COMPOUNDS</title><source>esp@cenet</source><creator>PHUKAN, Samiron ; SINDKHEDKAR, Milind ; PALLE, Venkata ; NAIR, Prathap ; WAGH, Pradip ; KAMBOJ, Rajender ; DUBE, Dagadu ; KHEDKAR, Nilesh ; SETHI, Sachin ; BALGUDE, Sudhakar ; PATIL, Pradeep ; TAMBE, Vikas ; SHUKLA, Manojkumar ; KAKADE, Ganesh</creator><creatorcontrib>PHUKAN, Samiron ; SINDKHEDKAR, Milind ; PALLE, Venkata ; NAIR, Prathap ; WAGH, Pradip ; KAMBOJ, Rajender ; DUBE, Dagadu ; KHEDKAR, Nilesh ; SETHI, Sachin ; BALGUDE, Sudhakar ; PATIL, Pradeep ; TAMBE, Vikas ; SHUKLA, Manojkumar ; KAKADE, Ganesh</creatorcontrib><description>Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, Formula (I) wherein, ring A, R1 to R5, X, Y, m, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.</description><language>eng ; lit</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240527&amp;DB=EPODOC&amp;CC=LT&amp;NR=4065575T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240527&amp;DB=EPODOC&amp;CC=LT&amp;NR=4065575T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PHUKAN, Samiron</creatorcontrib><creatorcontrib>SINDKHEDKAR, Milind</creatorcontrib><creatorcontrib>PALLE, Venkata</creatorcontrib><creatorcontrib>NAIR, Prathap</creatorcontrib><creatorcontrib>WAGH, Pradip</creatorcontrib><creatorcontrib>KAMBOJ, Rajender</creatorcontrib><creatorcontrib>DUBE, Dagadu</creatorcontrib><creatorcontrib>KHEDKAR, Nilesh</creatorcontrib><creatorcontrib>SETHI, Sachin</creatorcontrib><creatorcontrib>BALGUDE, Sudhakar</creatorcontrib><creatorcontrib>PATIL, Pradeep</creatorcontrib><creatorcontrib>TAMBE, Vikas</creatorcontrib><creatorcontrib>SHUKLA, Manojkumar</creatorcontrib><creatorcontrib>KAKADE, Ganesh</creatorcontrib><title>SUBSTITUTED TRICYCLIC COMPOUNDS</title><description>Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, Formula (I) wherein, ring A, R1 to R5, X, Y, m, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAPDnUKDvEMCQ1xdVEICfJ0jnT28XRWcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8T4hJgZmpqbmpiEhxkQoAQDLACIu</recordid><startdate>20240527</startdate><enddate>20240527</enddate><creator>PHUKAN, Samiron</creator><creator>SINDKHEDKAR, Milind</creator><creator>PALLE, Venkata</creator><creator>NAIR, Prathap</creator><creator>WAGH, Pradip</creator><creator>KAMBOJ, Rajender</creator><creator>DUBE, Dagadu</creator><creator>KHEDKAR, Nilesh</creator><creator>SETHI, Sachin</creator><creator>BALGUDE, Sudhakar</creator><creator>PATIL, Pradeep</creator><creator>TAMBE, Vikas</creator><creator>SHUKLA, Manojkumar</creator><creator>KAKADE, Ganesh</creator><scope>EVB</scope></search><sort><creationdate>20240527</creationdate><title>SUBSTITUTED TRICYCLIC COMPOUNDS</title><author>PHUKAN, Samiron ; SINDKHEDKAR, Milind ; PALLE, Venkata ; NAIR, Prathap ; WAGH, Pradip ; KAMBOJ, Rajender ; DUBE, Dagadu ; KHEDKAR, Nilesh ; SETHI, Sachin ; BALGUDE, Sudhakar ; PATIL, Pradeep ; TAMBE, Vikas ; SHUKLA, Manojkumar ; KAKADE, Ganesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_LT4065575TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; lit</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PHUKAN, Samiron</creatorcontrib><creatorcontrib>SINDKHEDKAR, Milind</creatorcontrib><creatorcontrib>PALLE, Venkata</creatorcontrib><creatorcontrib>NAIR, Prathap</creatorcontrib><creatorcontrib>WAGH, Pradip</creatorcontrib><creatorcontrib>KAMBOJ, Rajender</creatorcontrib><creatorcontrib>DUBE, Dagadu</creatorcontrib><creatorcontrib>KHEDKAR, Nilesh</creatorcontrib><creatorcontrib>SETHI, Sachin</creatorcontrib><creatorcontrib>BALGUDE, Sudhakar</creatorcontrib><creatorcontrib>PATIL, Pradeep</creatorcontrib><creatorcontrib>TAMBE, Vikas</creatorcontrib><creatorcontrib>SHUKLA, Manojkumar</creatorcontrib><creatorcontrib>KAKADE, Ganesh</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PHUKAN, Samiron</au><au>SINDKHEDKAR, Milind</au><au>PALLE, Venkata</au><au>NAIR, Prathap</au><au>WAGH, Pradip</au><au>KAMBOJ, Rajender</au><au>DUBE, Dagadu</au><au>KHEDKAR, Nilesh</au><au>SETHI, Sachin</au><au>BALGUDE, Sudhakar</au><au>PATIL, Pradeep</au><au>TAMBE, Vikas</au><au>SHUKLA, Manojkumar</au><au>KAKADE, Ganesh</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED TRICYCLIC COMPOUNDS</title><date>2024-05-27</date><risdate>2024</risdate><abstract>Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, Formula (I) wherein, ring A, R1 to R5, X, Y, m, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; lit
recordid cdi_epo_espacenet_LT4065575TT
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SUBSTITUTED TRICYCLIC COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A14%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PHUKAN,%20Samiron&rft.date=2024-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ELT4065575TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true